SEC Form 4 filings for ABBOTT LABORATORIESAbbott ProductsAbbott Investments Luxembourg S.A R.L.,

Insider trading of Laboratories Abbott Product..., a at MYL Mylan N.V.

Most recently Laboratories Abbott Product... sold 44,000,000 shares worth $1,830,400,000.00 on 23 March 2017.

Date
#
Company
Insider Title
Trans.
Transaction
Shares Price per share Total price Shares after Source
2017-03-23 Laboratories Abbott Product...
Sale 44,000,000 $41.60 $1,830,400,000
2017-03-23
25,750,000

About Mylan N.V.

Mylan N.V. logo

Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, brand name, and over-the-counter products worldwide. The company operates through three segments: North America, Europe, and Rest of World. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms. The company also manufactures and sells a portfolio of injectable products across various therapeutic areas, including respiratory and allergy, infectious disease, cardiovascular, oncology, and central nervous system and anesthesia; active pharmaceutical ingredients; antiretroviral therapy products for people living with HIV/AIDS; and products in the therapeutic categories, such as hepatology and critical care. In addition, it provides EpiPen Auto-Injector, which is used to treat severe allergic reactions; Perforomist Inhalation Solution, a formoterol fumarate inhalation solution for the maintenance treatment of bronchoconstriction in chronic obstructive pulmonary disorder patients; ULTIVA, an analgesic agent used during the induction and maintenance of general anesthesia for inpatient and outpatient procedures; and Dymista, which is used for the treatment of seasonal allergic rhinitis. The company markets its products to wholesalers, distributors, retail pharmacy chains, mail order pharmacies, and group purchasing organizations; and independent pharmacies, managed care organizations, hospitals, nursing homes, and pharmacy benefit managers. The company was formerly known as New Moon B.V. Mylan N.V. was founded in 1961 and is based in Hatfield, the United Kingdom.

  • Mylan N.V., Building 4, Hatfield AL10 9UL, United Kingdom
  • mylan.com
  • 44 17 0785 3000
Messenger